Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus: Clinical trial
Credit: Pixabay/CC0 Public Domain A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of ...
Read moreDetails
















